BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22323184)

  • 21. DNA damage response is suppressed by the high cyclin-dependent kinase 1 activity in mitotic mammalian cells.
    Zhang W; Peng G; Lin SY; Zhang P
    J Biol Chem; 2011 Oct; 286(41):35899-35905. PubMed ID: 21878640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
    Jowsey PA; Doherty AJ; Rouse J
    J Biol Chem; 2004 Dec; 279(53):55562-9. PubMed ID: 15456759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.
    Shibata A; Barton O; Noon AT; Dahm K; Deckbar D; Goodarzi AA; Löbrich M; Jeggo PA
    Mol Cell Biol; 2010 Jul; 30(13):3371-83. PubMed ID: 20421415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription.
    Khalil HS; Tummala H; Hupp TR; Zhelev N
    Exp Biol Med (Maywood); 2012 Jun; 237(6):622-34. PubMed ID: 22728709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.
    Hagemeier SR; Barlow EA; Meng Q; Kenney SC
    J Virol; 2012 Dec; 86(24):13360-70. PubMed ID: 23015717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.
    Mochan TA; Venere M; DiTullio RA; Halazonetis TD
    Cancer Res; 2003 Dec; 63(24):8586-91. PubMed ID: 14695167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR.
    Jowsey P; Morrice NA; Hastie CJ; McLauchlan H; Toth R; Rouse J
    DNA Repair (Amst); 2007 Oct; 6(10):1536-44. PubMed ID: 17553757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.
    Ching JK; Luebbert SH; Collins RL; Zhang Z; Marupudi N; Banerjee S; Hurd RD; Ralston L; Fisher JS
    Exp Physiol; 2013 Feb; 98(2):526-35. PubMed ID: 22941977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATM-dependent phosphorylation of the checkpoint clamp regulates repair pathways and maintains genomic stability.
    Shin MH; Yuan M; Zhang H; Margolick JB; Kai M
    Cell Cycle; 2012 May; 11(9):1796-803. PubMed ID: 22453082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.
    Song L; Lin C; Wu Z; Gong H; Zeng Y; Wu J; Li M; Li J
    PLoS One; 2011; 6(9):e25454. PubMed ID: 21980462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular imaging of the ATM kinase activity.
    Williams TM; Nyati S; Ross BD; Rehemtulla A
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):969-77. PubMed ID: 23726004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
    Qi Y; Schoene NW; Lartey FM; Cheng WH
    J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a high-content high-throughput screening assay for the discovery of ATM signaling inhibitors.
    Bardelle C; Boros J
    J Biomol Screen; 2012 Aug; 17(7):912-20. PubMed ID: 22653913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.
    Mandriota SJ; Buser R; Lesne L; Stouder C; Favaudon V; Maechler P; Béna F; Clément V; Rüegg C; Montesano R; Sappino AP
    J Biol Chem; 2010 Apr; 285(17):13092-106. PubMed ID: 20177072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Jacquemont C; Taniguchi T
    Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATM signaling and 53BP1.
    Zgheib O; Huyen Y; DiTullio RA; Snyder A; Venere M; Stavridi ES; Halazonetis TD
    Radiother Oncol; 2005 Aug; 76(2):119-22. PubMed ID: 16024119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair.
    Noon AT; Shibata A; Rief N; Löbrich M; Stewart GS; Jeggo PA; Goodarzi AA
    Nat Cell Biol; 2010 Feb; 12(2):177-84. PubMed ID: 20081839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways.
    Rappold I; Iwabuchi K; Date T; Chen J
    J Cell Biol; 2001 Apr; 153(3):613-20. PubMed ID: 11331310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.